These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24870551)

  • 1. Active pharmaceutical ingredients available as substances for extemporaneous preparation in veterinary medicine in the Czech Republic.
    Sklenář Z; Horáčková K; Bakhouche H
    Ceska Slov Farm; 2014 Apr; 63(2):71-4. PubMed ID: 24870551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The possibilities of innovation of extemporaneous preparation in pharmacies in the Czech Republic].
    Sklenář Z; Horáčková K
    Ceska Slov Farm; 2012 Feb; 61(1-2):11-6. PubMed ID: 22536647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
    Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
    N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extemporaneous magistral formulas for the topical treatment of pruritus : Proven and new options].
    Staubach P; Weisshaar E
    Hautarzt; 2016 Aug; 67(8):635-9. PubMed ID: 27341823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compounded preparations with nystatin for oral and oromucosal administration.
    Sklenár Z; Scigel V; Horácková K; Slanar O
    Acta Pol Pharm; 2013; 70(4):759-62. PubMed ID: 23923400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
    Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
    Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the type and frequency of extemporaneous formulations dispensed in hospital and community pharmacies.
    Ramtoola Z; Catibusic A; Ameen H; Cullen S; Barlow JW
    Explor Res Clin Soc Pharm; 2023 Dec; 12():100380. PubMed ID: 38146320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Drug Content, Stability Analysis, and Qualitative Assessment of Pharmacists' Opinions of Two Exemplar Extemporaneous Formulations.
    Kirkby M; Moffatt K; Rogers AM; McCague PJ; McElnay JC; Quinn C; McCullough LA; Barry J; Donnelly RF
    Molecules; 2020 Jul; 25(13):. PubMed ID: 32640709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations.
    Kiselova O; Maurina B; Sidlovska V
    Int J Pharm Compd; 2020; 24(6):491-500. PubMed ID: 33217739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.
    Vanhoorne V; Peeters E; Van Tongelen I; Boussery K; Wynendaele E; De Spiegeleer B; Remon JP; Vervaet C
    Orphanet J Rare Dis; 2019 Aug; 14(1):186. PubMed ID: 31370862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veterinary Compounding: Regulation, Challenges, and Resources.
    Davidson G
    Pharmaceutics; 2017 Jan; 9(1):. PubMed ID: 28075379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounded medication for patients with rare diseases.
    Dooms M; Carvalho M
    Orphanet J Rare Dis; 2018 Jan; 13(1):1. PubMed ID: 29301541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of drugs used in out-patient practice of veterinary medicine].
    Agelová J; Macesková B
    Ceska Slov Farm; 2005 Jan; 54(1):34-8. PubMed ID: 15751793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Conroy S
    Acta Paediatr; 2003 Apr; 92(4):408-10. PubMed ID: 12801103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacy compounding of medicinal shampoos: an update].
    Varçin M; Vandael A; Zier-Vercammen J
    J Pharm Belg; 2012 Dec; (4):38-48. PubMed ID: 23350210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development.
    Orubu ESF; Patani BO; Arhewoh MI
    Int J Pharm Compd; 2021; 25(6):475-481. PubMed ID: 34807842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.